LianBio CEO Yizhe Wang receives $20M in 2021
LianBio reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
LianBio reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, four LianBio executives received on average a compensation package of $9.4M, a 106% increase compared to previous year.
Yizhe Wang, Chief Executive Officer, received $20M in total. 93% of Wang's compensation, or $18M, was in option awards. Wang also received $240K in bonus, $461K in non-equity incentive plan, $313K in salary, as well as $422K in stock awards.
Debra Yu, President & Chief Strategy Officer, received a compensation package of $9.7M, which increased by 186% compared to previous year. 86% of the compensation package, or $8.4M, was in option awards.
Yi Larson, Chief Financial Officer, earned $7.8M in 2021.
Bing Li, Chief Executive Officer, received $680K in 2021, which decreases by 88% compared to 2020.